Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events

被引：3
|
作者：
Pisetsky, David S. [1 ,2 ]
机构：
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] VA Med Ctr, Med Res Serv, 508 Fulton St,151G, Durham, NC 27705 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷 / 06期
关键词：
disease activity; polymyalgia rheumatica; reactive arthritis; ARTHRITIS; CANCER;
D O I：
10.1136/annrheumdis-2018-213561
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：795 / 796
页数：2
相关论文
共 50 条
  • [31] Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
    Choi, Juwhan
    Lee, Sung Yong
    IMMUNE NETWORK, 2020, 20 (01)
  • [32] Cutaneous immune-related adverse events to immune checkpoint inhibitors: A dermatology perspective
    Muntyanu, Anastasiya
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB42 - AB42
  • [33] Equibalancing immune-related adverse events and anticancer activity of immune checkpoint inhibitors
    Seeruttun, Sharvesh Raj
    THORACIC CANCER, 2019, 10 (10) : 1855 - 1856
  • [34] Do immune-related adverse events correlate with response to immune checkpoint inhibitors?
    Saleh, Khalil
    Khalife-Saleh, Nadine
    Kourie, Hampig Raphael
    IMMUNOTHERAPY, 2019, 11 (04) : 257 - 259
  • [35] Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?
    Michot, J. M.
    Lazarovici, J.
    Tieu, A.
    Champiat, S.
    Voisin, A. L.
    Ebbo, M.
    Godeau, B.
    Michel, M.
    Ribrag, V.
    Lambotte, O.
    EUROPEAN JOURNAL OF CANCER, 2019, 122 : 72 - 90
  • [36] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Zhong, Li
    Wu, Qing
    Chen, Fuchun
    Liu, Junjin
    Xie, Xianhe
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2559 - 2576
  • [37] Immune-Related Hematologic Adverse Events in the Context of Checkpoint Inhibitors
    Saliba, Antoine
    Xie, Zhuoer
    Higgins, Ally
    Andrade-Gonzalez, Xavier A.
    Fuentes-Bayne, Harry E.
    Hampel, Paul J.
    Fonkoua, Lionel Kankeu
    Childs, Daniel
    Rakshit, Sagar
    Bezerra, Evandro D.
    Lou, Yanyan
    Rivera, Candido E.
    Price, Katharine
    Yan, Yiyi
    Schwecke, Anna
    Block, Matthew S.
    Thanarajasingam, Uma
    Thanarajasingam, Gita
    Wolanskyj, Alexandra P.
    Marshall, Ariela L.
    Kottschade, Lisa A.
    Go, Ronald S.
    Al-Kali, Aref
    BLOOD, 2020, 136
  • [38] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [39] Treatment options for immune-related adverse events associated with immune checkpoint inhibitors
    Chen, Yu Hua
    Kovacs, Tamas
    Ferdinandy, Peter
    Varga, Zoltan V.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024,
  • [40] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Li Zhong
    Qing Wu
    Fuchun Chen
    Junjin Liu
    Xianhe Xie
    Cancer Immunology, Immunotherapy, 2021, 70 : 2559 - 2576
12345